In fact, a recent paper showed that ST6Gal-II downregulation inhibited cancer progression, cell adhesion and invasion, and suppressed ICAM-1, VCAM-1, CD24, MMP2, MMP9, and CXCR4 expression in breast cancer cells. Here, MMP2 is linked to breast carcinoma.